当前位置:首页 - 行情中心 - 惠泰医疗(688617) - 财务分析

惠泰医疗

(688617)

  

流通市值:358.91亿  总市值:358.91亿
流通股本:1.41亿   总股本:1.41亿

惠泰医疗(688617)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.15亿元,每股收益4.42元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益303725.03万元,未分配利润209404.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产346075.30万元,负债42350.27万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,867,437,461.291,213,804,906.53564,276,710.672,065,801,597.74
营业总成本1,191,415,119.57752,300,167.35357,739,406.51,339,013,056.93
其他经营收益
营业利润710,662,982.14483,304,979.16215,668,911.8753,691,427.41
利润总额705,751,543.8479,340,286.62213,819,515.86745,967,278.53
净利润614,819,029.79418,900,671.88180,135,141.87658,167,740.72
每股收益
其他综合收益4,244,439.092,191,973.46-138,078.4-22,575,353.34
综合收益总额619,063,468.88421,092,645.34179,997,063.47635,592,387.38
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,978,815,743.521,781,575,753.241,750,830,787.651,616,687,606.56
非流动资产:
非流动资产合计1,481,937,296.441,440,924,761.171,393,761,981.581,364,010,162.26
资产总计3,460,753,039.963,222,500,514.413,144,592,769.232,980,697,768.82
流动负债:
流动负债合计367,679,331.39348,102,859.99371,231,509.51405,968,659.57
非流动负债:
非流动负债合计55,823,394.6645,117,968.0736,906,749.1419,885,806.72
负债合计423,502,726.05393,220,828.06408,138,258.65425,854,466.29
所有者权益(或股东权益):
归属于母公司股东权益合计2,988,822,083.242,794,367,389.652,700,953,801.472,516,339,545.43
股东权益合计3,037,250,313.912,829,279,686.352,736,454,510.582,554,843,302.53
负债和股东权益合计3,460,753,039.963,222,500,514.413,144,592,769.232,980,697,768.82
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,143,203,311.231,398,374,210.86661,666,868.332,321,424,686.74
经营活动现金流出小计1,467,144,111.77953,725,557.93495,004,280.841,578,034,675.76
经营活动产生的现金流量净额676,059,199.46444,648,652.93166,662,587.49743,390,010.98
投资活动产生的现金流量:
投资活动现金流入小计1,735,713,312.31,212,932,925.25696,565,764.862,484,562,605.42
投资活动现金流出小计2,329,491,613.41,478,864,010.4744,584,702.923,102,354,358.13
投资活动产生的现金流量净额-593,778,301.1-265,931,085.15-48,018,938.06-617,791,752.71
筹资活动产生的现金流量:
筹资活动现金流入小计43,776,853.7827,373,979.28-91,033,523.52
筹资活动现金流出小计231,415,118.32224,066,169.412,856,896.05398,932,446.96
筹资活动产生的现金流量净额-187,638,264.54-196,692,190.13-2,856,896.05-307,898,923.44
汇率变动对现金及现金等价物的影响-876,175.642,149,549.56799,616.44-13,002,729.01
现金及现金等价物净增加额-106,233,541.82-15,825,072.79116,586,369.82-195,303,394.18
期末现金及现金等价物余额974,854,369.211,065,262,838.241,197,674,280.851,081,087,911.03
补充资料:
现金及现金等价物的净增加额--15,825,072.79--195,303,394.18
最新报告期:2025-12-18
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券宋硕,陈竹,曾令鹏5.847.249.352025-12-18
中信建投郑涛,朱琪璋,王在存,贺菊颖5.867.589.852025-12-09
中信建投郑涛,朱琪璋,王在存,贺菊颖5.907.579.812025-11-14
招商证券梁广楷,许菲菲,郭子娴5.937.509.782025-11-10
兴业证券孙媛媛,黄翰漾5.967.729.972025-11-06
TOP↑